INSIGHTS AND PERSPECTIVES

NEW YORK — Reckitt Benckiser on Friday made an offer to acquire all of the outstanding shares of VMS maker Schiff Nutrition for $42 per share in cash, or approximately $1.4 billion — a premium of 23.5% more than the $34 per share offer Bayer HealthCare announced Oct. 30. 

NEW YORK — Spurred by health reform and other factors, a "golden era" could be approaching for drug companies as they reinvent themselves, according to a new report by PwC.

The report, "Pharma 2020: From Vision to Decision," said that the industry was on the verge of an era of renewed productivity and prosperity, but its success was not guaranteed.

ATLANTA — A majority of retailers say delivering a consistent customer experience is their top priority this holiday season, according to a new survey.

Supply chain and retail technology provider RedPrairie released results of its "Holiday Hiring Snapshot" survey of 250 big-box, specialty, grocery, convenience store and food service retailers based in the United States, finding that nearly 60% cited the importance of consistency, with 29% saying they would hire more seasonal workers this year than last year.

NEW YORK — Latinas prefer details in beauty products and follow a multi-pronged beauty regimen, according to a new study.

WOONSOCKET, R.I. — CVS Caremark reported strong numbers on both the retail and PBM sides of its business — but the real bombshell for analysts on the call was the news that the company has raised its estimate on the number of Express Script patients that CVS feels it can keep from going back to Walgreens.

LONDON — As part of its multi-channel strategy, Boots UK is currently testing the use of iPads to support in-store ordering across 30 stores, the London-based drug store retailer recently announced. 

Earlier this week, DSN reported that members of a prescription drug program offered by Humana to Medicare beneficiaries will soon be able to obtain 10 generic hypertension drugs from Walmart for a penny.

It's certainly good news for people with high blood pressure, but it also has big implications for the pharmacy retail industry.

NEW YORK — Liquor can cost $2 more at liquor stores in states where the government has a monopoly on sales than at privately owned stores, according to a new study.

Researchers at Boston University School of Public Health, the Boston Medical Center and Johns Hopkins University analyzed the prices of 74 different alcohol brands in 13 "control states" — states where the government has a monopoly on liquor sales — and at 50 private retailers in "license states." The study appeared online in the journal Addiction.